ArticleCadernos de saude publica2026
A portrait of electronic nicotine delivery systems use in Brazil: findings from the 2019-2023 Vigitel survey.
Article in Cadernos de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of electronic nicotine delivery systems (ENDS) has been increasing globally, raising concerns about their impact on public health, particularly among young adults. In Brazil, despite strong tobacco control policies, data on the prevalence of ENDS use and its associated factors remain limited. This study aimed to analyze sociodemographic and behavioral factors associated with lifetime ENDS use among Brazilian adults from 2019 to 2023. Data from four national surveys conducted in 2019, 2020, 2021, and 2023, including 126,681 participants, were analyzed. Crude and adjusted logistic regression models were applied to estimate odds ratios and 95% confidence intervals to assess associations between sociodemographic characteristics, health behaviors, and lifetime ENDS use. All analyses were weighted to account for the complex sampling design and stratified by survey year. Lifetime ENDS use was significantly higher among young adults (18-24 years), males, individuals living in the Central-West and South regions, and those reporting binge drinking and smoking. Higher educational attainment and prolonged screen time (≥ 3 hours/day) were also positively associated with ENDS use. Lifetime ENDS use in Brazil is influenced by sociodemographic and lifestyle factors, with higher prevalence among young adult males with higher education levels and residents of specific regions. These findings highlight the need for targeted public health strategies aimed at populations at higher risk to curb the growing use of ENDS and prevent potential health consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.